Gastroenteritis attributable to rotavirus in hospitalized Saudi Arabian children in the period 2007–2008

Mohamed Khalil,1 Esam Azhar,2,3 Moujahed Kao,3 Noura Al-Kaiedi,3 Hatim Alhani,4 Ibrahim Al Olayan,5 Robert Pawinski,6,7 Kusuma Gopala,8 Walid Kandeil,7 Sameh Anis,7,9 Leen Jan Van Doorn,10 Rodrigo DeAntonio7 1Public Health and Research Development, Ministry of Health, Riyadh, Saudi Arabia; 2Medical...

Full description

Bibliographic Details
Main Authors: Khalil M, Azhar E, Kao M, Al-Kaiedi N, Alhani H, Al Olayan I, Pawinski R, Gopala K, Kandeil W, Anis S, Van Doorn LJ, DeAntonio R
Format: Article
Language:English
Published: Dove Medical Press 2015-02-01
Series:Clinical Epidemiology
Online Access:http://www.dovepress.com/gastroenteritis-attributable-to-rotavirus-in-hospitalized-saudi-arabia-peer-reviewed-article-CLEP
id doaj-82b5763607cb4287a7d6c003ecaffa29
record_format Article
spelling doaj-82b5763607cb4287a7d6c003ecaffa292020-11-24T20:56:00ZengDove Medical PressClinical Epidemiology1179-13492015-02-012015default12913720396Gastroenteritis attributable to rotavirus in hospitalized Saudi Arabian children in the period 2007–2008Khalil MAzhar EKao MAl-Kaiedi NAlhani HAl Olayan IPawinski RGopala KKandeil WAnis SVan Doorn LJDeAntonio R Mohamed Khalil,1 Esam Azhar,2,3 Moujahed Kao,3 Noura Al-Kaiedi,3 Hatim Alhani,4 Ibrahim Al Olayan,5 Robert Pawinski,6,7 Kusuma Gopala,8 Walid Kandeil,7 Sameh Anis,7,9 Leen Jan Van Doorn,10 Rodrigo DeAntonio7 1Public Health and Research Development, Ministry of Health, Riyadh, Saudi Arabia; 2Medical Laboratory Technology Department, Faculty of Applied Medical Sciences, 3Special Infectious Agents Unit, Bio-Safety Level 3, King Fahad Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia; 4Maternity and Children’s Hospital, Dammam, Saudi Arabia; 5Maternity and Children’s Hospital, Qassim, Saudi Arabia; 6Reckitt Benckiser Pharmaceuticals, Slough, UK; 7GlaxoSmithKline Vaccines, Wavre, Belgium; 8GlaxoSmithKline Pharmaceuticals Ltd, Bangalore, Karnataka, India; 9AbbVie Biopharmaceuticals GmbH, Dubai, United Arab Emirates; 10DDL Diagnostic Laboratory, Rijswijk, the Netherlands Purpose: Rotavirus (RV) is a leading cause of severe gastroenteritis (GE) in children across the world. As there is a lack of epidemiological data for RV gastroenteritis (RVGE) in Saudi Arabia, this hospital-based study was designed to estimate the disease burden of RVGE and assess the prevalent RV types in Saudi children younger than 5 years of age.Patients and methods: Children hospitalized for acute GE were enrolled at four pediatric referral hospitals in Saudi Arabia. The study was conducted from February 2007 to March 2008 and used the World Health Organization's generic protocol for RVGE surveillance. The Vesikari severity scale was used to assess the severity of RVGE. Stool samples were tested for RV using an enzyme-linked immunosorbent assay. Samples were further typed by reverse transcriptase–polymerase chain reaction and hybridization assay for determining the G and P types.Results: A total of 1,007 children were enrolled; the final analysis included 970 children, of whom 395 were RV positive, 568 were RV negative, and seven had unknown RV status. The proportion of RVGE among GE hospitalizations was 40.7% (95% confidence interval: 37.6–43.9). The highest percentage of RVGE hospitalizations (83.1%) was seen in children younger than 2 years of age. The highest proportion of RV among GE hospitalizations was in June 2007 with 57.1%. The most common RV types detected were G1P[8] (49.3%), G1G9P[8] (13.2%), and G9P[8] (9.6%). Before hospitalization, severe GE episodes occurred in 88.1% RV-positive and 79.6% RV-negative children. Overall, 94% children had recovered by the time they were discharged. Two children (one RV positive and one RV negative) died due to GE complications.Conclusion: RVGE is responsible for a high proportion of hospitalizations in Saudi children younger than 5 years of age. Routine RV vaccination has therefore been introduced into the national immunization program and may help reduce the morbidity, mortality, and disease burden associated with RVGE in Saudi Arabia. Keywords: disease burden, Saudi Arabia, rotavirus, RVGE, epidemiologyhttp://www.dovepress.com/gastroenteritis-attributable-to-rotavirus-in-hospitalized-saudi-arabia-peer-reviewed-article-CLEP
collection DOAJ
language English
format Article
sources DOAJ
author Khalil M
Azhar E
Kao M
Al-Kaiedi N
Alhani H
Al Olayan I
Pawinski R
Gopala K
Kandeil W
Anis S
Van Doorn LJ
DeAntonio R
spellingShingle Khalil M
Azhar E
Kao M
Al-Kaiedi N
Alhani H
Al Olayan I
Pawinski R
Gopala K
Kandeil W
Anis S
Van Doorn LJ
DeAntonio R
Gastroenteritis attributable to rotavirus in hospitalized Saudi Arabian children in the period 2007–2008
Clinical Epidemiology
author_facet Khalil M
Azhar E
Kao M
Al-Kaiedi N
Alhani H
Al Olayan I
Pawinski R
Gopala K
Kandeil W
Anis S
Van Doorn LJ
DeAntonio R
author_sort Khalil M
title Gastroenteritis attributable to rotavirus in hospitalized Saudi Arabian children in the period 2007–2008
title_short Gastroenteritis attributable to rotavirus in hospitalized Saudi Arabian children in the period 2007–2008
title_full Gastroenteritis attributable to rotavirus in hospitalized Saudi Arabian children in the period 2007–2008
title_fullStr Gastroenteritis attributable to rotavirus in hospitalized Saudi Arabian children in the period 2007–2008
title_full_unstemmed Gastroenteritis attributable to rotavirus in hospitalized Saudi Arabian children in the period 2007–2008
title_sort gastroenteritis attributable to rotavirus in hospitalized saudi arabian children in the period 2007–2008
publisher Dove Medical Press
series Clinical Epidemiology
issn 1179-1349
publishDate 2015-02-01
description Mohamed Khalil,1 Esam Azhar,2,3 Moujahed Kao,3 Noura Al-Kaiedi,3 Hatim Alhani,4 Ibrahim Al Olayan,5 Robert Pawinski,6,7 Kusuma Gopala,8 Walid Kandeil,7 Sameh Anis,7,9 Leen Jan Van Doorn,10 Rodrigo DeAntonio7 1Public Health and Research Development, Ministry of Health, Riyadh, Saudi Arabia; 2Medical Laboratory Technology Department, Faculty of Applied Medical Sciences, 3Special Infectious Agents Unit, Bio-Safety Level 3, King Fahad Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia; 4Maternity and Children’s Hospital, Dammam, Saudi Arabia; 5Maternity and Children’s Hospital, Qassim, Saudi Arabia; 6Reckitt Benckiser Pharmaceuticals, Slough, UK; 7GlaxoSmithKline Vaccines, Wavre, Belgium; 8GlaxoSmithKline Pharmaceuticals Ltd, Bangalore, Karnataka, India; 9AbbVie Biopharmaceuticals GmbH, Dubai, United Arab Emirates; 10DDL Diagnostic Laboratory, Rijswijk, the Netherlands Purpose: Rotavirus (RV) is a leading cause of severe gastroenteritis (GE) in children across the world. As there is a lack of epidemiological data for RV gastroenteritis (RVGE) in Saudi Arabia, this hospital-based study was designed to estimate the disease burden of RVGE and assess the prevalent RV types in Saudi children younger than 5 years of age.Patients and methods: Children hospitalized for acute GE were enrolled at four pediatric referral hospitals in Saudi Arabia. The study was conducted from February 2007 to March 2008 and used the World Health Organization's generic protocol for RVGE surveillance. The Vesikari severity scale was used to assess the severity of RVGE. Stool samples were tested for RV using an enzyme-linked immunosorbent assay. Samples were further typed by reverse transcriptase–polymerase chain reaction and hybridization assay for determining the G and P types.Results: A total of 1,007 children were enrolled; the final analysis included 970 children, of whom 395 were RV positive, 568 were RV negative, and seven had unknown RV status. The proportion of RVGE among GE hospitalizations was 40.7% (95% confidence interval: 37.6–43.9). The highest percentage of RVGE hospitalizations (83.1%) was seen in children younger than 2 years of age. The highest proportion of RV among GE hospitalizations was in June 2007 with 57.1%. The most common RV types detected were G1P[8] (49.3%), G1G9P[8] (13.2%), and G9P[8] (9.6%). Before hospitalization, severe GE episodes occurred in 88.1% RV-positive and 79.6% RV-negative children. Overall, 94% children had recovered by the time they were discharged. Two children (one RV positive and one RV negative) died due to GE complications.Conclusion: RVGE is responsible for a high proportion of hospitalizations in Saudi children younger than 5 years of age. Routine RV vaccination has therefore been introduced into the national immunization program and may help reduce the morbidity, mortality, and disease burden associated with RVGE in Saudi Arabia. Keywords: disease burden, Saudi Arabia, rotavirus, RVGE, epidemiology
url http://www.dovepress.com/gastroenteritis-attributable-to-rotavirus-in-hospitalized-saudi-arabia-peer-reviewed-article-CLEP
work_keys_str_mv AT khalilm gastroenteritisattributabletorotavirusinhospitalizedsaudiarabianchildrenintheperiod2007ndash2008
AT azhare gastroenteritisattributabletorotavirusinhospitalizedsaudiarabianchildrenintheperiod2007ndash2008
AT kaom gastroenteritisattributabletorotavirusinhospitalizedsaudiarabianchildrenintheperiod2007ndash2008
AT alkaiedin gastroenteritisattributabletorotavirusinhospitalizedsaudiarabianchildrenintheperiod2007ndash2008
AT alhanih gastroenteritisattributabletorotavirusinhospitalizedsaudiarabianchildrenintheperiod2007ndash2008
AT alolayani gastroenteritisattributabletorotavirusinhospitalizedsaudiarabianchildrenintheperiod2007ndash2008
AT pawinskir gastroenteritisattributabletorotavirusinhospitalizedsaudiarabianchildrenintheperiod2007ndash2008
AT gopalak gastroenteritisattributabletorotavirusinhospitalizedsaudiarabianchildrenintheperiod2007ndash2008
AT kandeilw gastroenteritisattributabletorotavirusinhospitalizedsaudiarabianchildrenintheperiod2007ndash2008
AT aniss gastroenteritisattributabletorotavirusinhospitalizedsaudiarabianchildrenintheperiod2007ndash2008
AT vandoornlj gastroenteritisattributabletorotavirusinhospitalizedsaudiarabianchildrenintheperiod2007ndash2008
AT deantonior gastroenteritisattributabletorotavirusinhospitalizedsaudiarabianchildrenintheperiod2007ndash2008
_version_ 1716791144768077824